US Patent Issued to CHENGDU JINRUI FOUNDATION BIOTECH on Sept. 23 for "Selective dihydropyrrolopyrimidine JAK2 inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,238, issued on Sept. 23, was assigned to CHENGDU JINRUI FOUNDATION BIOTECH Co. LTD. (Chengdu, China).

"Selective dihydropyrrolopyrimidine JAK2 inhibitors" was invented by Nongnong Wei (Shanghai), Hua Jin (Shanghai), Yongyong Zheng (Shanghai), Feng Zhou (Shanghai) and Meihua Huang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the technical field of biomedicine, particularly to a selective dihydropyrrolopyrimidine JAK2 inhibitor or a pharmaceutically acceptable salt thereof. Compared with the prior art, the pyrrolopyrimidine compounds, stereoisomers and pharmaceutically acceptable salts thereof provided by ...